The development of a vaccine to avoid norovirus infections continues to

The development of a vaccine to avoid norovirus infections continues to be centered on immunization at a mucosal surface, but continues to be limited by the reduced immunogenicity of self-assembling Norwalk virus-like particles (NV VLPs) delivered enterically or at sinus surfaces. immunogenicity regardless of the lack or existence of GelSite. AP24534 We interpret these data… Continue reading The development of a vaccine to avoid norovirus infections continues to